9-Chloro-2-benzyl-1,2,3,4-tetrahydro-2-azaacridine

Catalog No. :
ACTPVZ196
CAS No. :
219537-08-3
Molecular Formula :
C19H17ClN2
Molecular Weight :
308.81

IUPAC Name:2-benzyl-10-chloro-1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine

9-Chloro-2-benzyl-1,2,3,4-tetrahydro-2-azaacridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$155.00Login to see priceInquiryInquiry
250mg95%$308.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-Chloro-2-benzyl-1,2,3,4-tetrahydro-2-azaacridine
IUPAC Name2-benzyl-10-chloro-1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine
Molecular FormulaC19H17ClN2
Molecular Weight308.81
SMILESClC1=C(CN(CC2=CC=CC=C2)CC3)C3=NC4=CC=CC=C41
InChI KeyBSBOXQXOZZHMDR-UHFFFAOYSA-N
Synonym9-Chloro-2-benzyl-1,2,3,4-tetrahydro-2-azaacridine;10-Chloro-1,2,3,4-tetrahydro-2-(phenylmethyl)-benzo[b][1,6]naphthyridine;Benzo[b][1,6]naphthyridine, 10-chloro-1,2,3,4-tetrahydro-2-(phenylmethyl)-;2-benzyl-10-chloro-1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine
CAS No.219537-08-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTPVZ196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTPVZ196 route product structure diagram
    ACTPVZ196219537-08-3
Inquiry

2. ACTPVZ196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACTPVZ196 route product structure diagram
    ACTPVZ196219537-08-3
Inquiry

Comments (0)